Biotech RadarJobs updated

COMPANY

Uptake Medical

HQ: San Jose, CA source · uptakemedical.com ↗

Keywords: respiratory Non Small Cell Lung Cancer Metastatic Lung Cancer Lung Cancer Emphysema or COPD Emphysema Bronchoscopic Thermal Vapor Ablation Treatment plus Optimal Medical Therapy

Location: San Jose, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

5Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): Vapor Ablation for Localized Cancer Lesions source ↗
  2. Trial start Not phased (device or behavioral study): A Randomized Controlled Trial of InterVapor® in France - The TARGET Trial source ↗
  3. Trial start Not phased (device or behavioral study): Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) source ↗
  4. Trial start Not phased (device or behavioral study): A Pilot Study to Assess Treatment of Patients With Homogeneous Emphysema Using Sequential Segmental Bronchoscopic Thermal Vapor Ablation (NEXT STEP) source ↗
  5. Trial start —: Post-Market BTVA Registry source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 5

RecordTitlePhaseStatusStartPrimary completion
NCT03514329Vapor Ablation for Localized Cancer LesionsNot phased (device or behavioral study)Not yet recruitingSep 1, 2026Mar 30, 2028 (estimated)
NCT05118269A Randomized Controlled Trial of InterVapor® in France - The TARGET TrialNot phased (device or behavioral study)TerminatedJul 21, 2023Jun 4, 2024 (actual)
NCT03318406Post-Market BTVA RegistryNot listedRecruitingMar 22, 2018Dec 1, 2027 (estimated)
NCT03670121A Pilot Study to Assess Treatment of Patients With Homogeneous Emphysema Using Sequential Segmental Bronchoscopic Thermal Vapor Ablation (NEXT STEP)Not phased (device or behavioral study)CompletedAug 28, 2018Jun 12, 2020 (actual)
NCT03198468Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE)Not phased (device or behavioral study)CompletedNov 21, 2018Aug 20, 2019 (actual)
Feedback